Atlas Trials

Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients

Clinical trial NCT01832285 · UNKNOWN

Trial details

NCT number
NCT01832285
Sponsor
Sha'ar Menashe Mental Health Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SCHIZOPHRENIA 1 (Disorder)
Start date
2012-12-01
Primary completion
2013-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.